Islamabad, May 20, 2025: In a significant development for Pakistan’s pharmaceutical industry, Ferzsons Laboratories Limited (PSX: FEROZ) has set its sights on acquiring Barrett Hodgson Pakistan (Pvt.) Limited, signaling a bold move toward expansion.
This strategic step, backed by a powerful consortium of local business giants, could reshape the competitive landscape in the country’s health sector.
The announcement came after an urgent board meeting held on May 17, 2025, where Ferzsons’ leadership reviewed a detailed proposal presented by its Investment Committee.
Following a thorough discussion, the Board of Directors granted full authority to the company’s Chief Executive Officer and Chief Financial Officer to spearhead the due diligence process.
This includes engaging expert advisors, managing legal and financial documentation, and securing necessary financial guarantees to move the process forward.
The potential acquisition of Barrett Hodgson Pakistan, a well-established name in the pharmaceutical market, represents Ferzsons’ ambition to diversify and strengthen its product portfolio.
According to sources familiar with the matter, the deal is being pursued as part of a collaborative effort with other major players in the business community—a move that could create powerful synergies in research, distribution, and innovation.
While no final transaction has taken place yet, Ferzsons emphasized that all decisions regarding the purchase price and level of equity investment will be made after completing the due diligence and obtaining the required regulatory approvals.
Read More: Govt Set to Launch Energy-Saving Fans Scheme on Easy Installments
Industry analysts view this development as a positive signal for investor confidence in Pakistan’s pharma sector, which has seen increasing demand and growth despite economic headwinds.
Read More: Govt Plans Ban on Non-Filers Buying Cars, Property in IMF-Linked Budget
Compared to past consolidations in the industry, this initiative could set a new precedent in corporate collaboration and strategic investment.
